C6: A monoclonal antibody specific for a fibronectin epitope situated at the interface between the oncofoetal extra-domain B and the repeat III8

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Ventura, Elisa ^a,d   Cordazzo, Cinzia ^b   Quarto, Rodolfo ^c   Zardi, Luciano ^b   Rosano, Camillo ^c  

^a G GASLINI INSTITUTE   (Italy)

^b Advanced Biotechnology Center   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; FIBRONECTIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY C6; UNCLASSIFIED DRUG; ANTIBODY; ISOPROTEIN; ONCOFETAL FIBRONECTIN; PROTEIN BINDING; RECOMBINANT PROTEIN; RNA PRECURSOR;

ADULT; AMINO ACID SEQUENCE; ANIMAL TISSUE; ANTIBODY AFFINITY; ANTIBODY COMBINING SITE; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; FETUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOLECULAR DOCKING; MOUSE; NONHUMAN; ONCOFETAL EXTRA DOMAIN B; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; TYPE III REPEAT 8; ANIMAL; CHEMISTRY; COMPUTER SIMULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; MUTATION; NEOVASCULARIZATION (PATHOLOGY); PROTEIN CONFORMATION; PROTEIN TERTIARY STRUCTURE;

ANIMALS; ANTIBODIES; ANTIBODIES, MONOCLONAL; COMPUTER SIMULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FIBRONECTINS; HUMANS; MICE; MUTATION; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; RNA PRECURSORS;

EID: 84959450416     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0148103     Document Type: Article

References (22)

1. Yamada KM, Clark RAF. Provisional Matrix. In: Clark RAF, ed. The Molecular and Cellular Biology of Wound Repair. New York: Plenum Press; 1996;51-93.
2. Pankov R, Yamada KM. Fibronectin at a glance. J Cell Sci. 2002; 115(Pt 20):3861-3. PMID: 12244123
3. Zardi L, Carnemolla B, Siri A, Petersen TE, Paolella G, Sebastio G, et al. Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon. EMBO J. 1987; 6(8):2337-42. PMID: 2822387
4. Carnemolla B, Balza E, Siri A, Zardi L, Nicotra MR, Bigotti A, et al. A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. J Cell Biol. 1989; 108(3):1139-48. PMID: 2646306
5. Kosmehl H, Berndt A, Katenkamp D. Molecular variants of fibronectin and laminin: structure, physiological occurrence and histopathological aspects. Virchows Arch. 1996; 429(6):311-22. PMID: 8982375
6. Castellani P, Borsi L, Carnemolla B, Birò A, Dorcaratto A, Viale GL, et al. Differentiation between highand low-grade astrocytoma using a human recombinant antibody to the extra domain-B of fibronectin. Am J Pathol. 2002; 161(5):1695-700. PMID: 12414516
7. Castellani P, Viale G, Dorcaratto A, Nicolo G, Kaczmarek J, Querze G, et al. The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis. Int J Cancer. 1994; 59(5):612-8. PMID: 7525495
8. Kaczmarek J, Castellani P, Nicolo G, Spina B, Allemanni G, Zardi L. Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues. Int J Cancer. 1994; 59(1):11-6. PMID: 7927891
9. Mariani G, Lasku A, Balza E, Gaggero B, Motta C, Di Luca L, et al. Tumor targeting potential of the monoclonal antibody BC-1 against oncofetal fibronectin in nude mice bearing human tumor implants. Cancer. 1997; 80(12 Suppl):2378-84. PMID: 9406686
10. Carnemolla B, Neri D, Castellani P, Leprini A, Neri G, Pini A, et al. Phage antibodies with pan-species recognition of the oncofoetal angiogenesis marker fibronectin ED-B domain. Int J Cancer. 1996; 68 (3):397-405. PMID: 8903484
11. Neri D, Bicknell R. Tumour vascular targeting. Nat Rev Cancer. 2005; 5(6):436-46. PMID: 15928674
12. Berndorff D, Borkowski S, Moosmayer D, Viti F, Müller-Tiemann B, Sieger S, et al. Imaging of tumor angiogenesis using 99mTc-labeled human recombinant anti-ED-B fibronectin antibody fragments. J Nucl Med. 2006; 47(10):1707-16. PMID: 17015908
13. Sauer S, Erba PA, Petrini M, Menrad A, Giovannoni L, Grana C, et al. Expression of the oncofetal EDB-containing fibronectin isoform in hematologic tumors enables ED-B-targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients. Blood. 2009; 113(10):22
14. Chen S, Chakrabarti R, Keats EC, Chen M, Chakrabarti S, Khan ZA. Regulation of vascular endothelial growth factor expression by extra domain B segment of fibronectin in endothelial cells. Invest Ophthalmol Vis Sci. 2012; 53(13):8333-43. doi: 10.1167/iovs.12-9766 PMID: 23150625
15. Kraft S, Klemis V, Sens C, Lenhard T, Jacobi C, Samstag Y, et al. Identification and characterization of a unique role for EDB fibronectin in phagocytosis. J Mol Med (Berl). 2015; 65-74.
16. Bencharit S, Bin Cui C, Siddiqui A, Howard-Williams EL, Sondek J, Zuobi-Hasona K, et al. Structural insights into fibronectin type III domain-mediated signaling. J Mol Biol. 2007; 367(2):303-9. PMID: 17261313
17. Balza E, Sassi F, Ventura E, Parodi A, Fossati S, Blalock W, et al. A novel human fibronectin cryptic sequence unmasked by the insertion of the angiogenesis-associated extra type III domain B. Int J Cancer. 2009; 125(4):751-8. doi: 10.1002/ijc.24473 PMID: 19479996
18. Ventura E, Sassi F, Parodi A, Balza E, Borsi L, Castellani P, et al. Alternative splicing of the angiogenesis associated extra-domain B of fibronectin regulates the accessibility of the B-C loop of the type III repeat 8. PLoS One. 2010; 5(2):e9145. doi: 10.1371/journal.pone.0009145 PMID: 20161770
19. Kelley LA, Sternberg MJE. Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc. 2009; 4(3):363-71. doi: 10.1038/nprot.2009.2 PMID: 19247286
20. Brünger AT, Adams PD, Clore GM, De Lano WL, Gros P, Grosse-Kunstleve RW, et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr. 1998; 54(Pt 5):905-21. PMID: 9757107
21. Comeau SR, Kozakov D, Brenke R, Shen Y, Beglov D, Vajda S. ClusPro: performance in CAPRI rounds 6-11 and the new server. Proteins. 2007; 69(4):781-5. PMID: 17876812
22. Schiefner A, Gebauer M, Skerra A. Extra-domain B in oncofetal fibronectin structurally promotes fibrillar head-to-tail dimerization of extracellular matrix protein. J Biol Chem. 2012; 287(21):17578-88. doi: 10.1074/jbc.M111.303131 PMID: 22442152